Our mission is to provide advocacy and support to those affected by maternal alloimmunization and its comorbid condition, hemolytic disease of the fetus and newborn. Maternal Alloimmunization Foundation aims to prevent stillbirth and neonatal mortality and morbidity caused by HDFN. We intend to provide patient support through education and have the intent to aid in the improvement of health-care practices for the conditions.
Main program · fiscal year 2025
Our mission is to provide advocacy and support to those affected by maternal alloimmunization and its comorbid condition, hemolytic disease of the fetus and newborn. Maternal Alloimmunization Foundation aims to prevent stillbirth and neonatal mortality and morbidity caused by HDFN. We intend to provide patient support through education and have the intent to aid in the improvement of health-care p… Read more
Our mission is to provide advocacy and support to those affected by maternal alloimmunization and its comorbid condition, hemolytic disease of the fetus and newborn. Maternal Alloimmunization Foundation aims to prevent stillbirth and neonatal mortality and morbidity caused by HDFN. We intend to provide patient support through education and have the intent to aid in the improvement of health-care practices for the conditions.
$17,293 spent
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$105,277Fiscal year 2025
Expenses$43,577Fiscal year 2025
Total assets—Fiscal year 2025
Total liabilities—Fiscal year 2025
Fiscal year ending July2025
Revenue$105,277
Expenses$43,577
Net income$61,700
Net assets$90,876
Notable sources of revenue
Percent of total revenue
Contributions
$105,277
100.0%
Program services
—
—
Investment income
—
—
Other (net)
$0
0.0%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$90,876
Compensation
Not in our extract for this year.
Fiscal year ending July2024
Revenue$17,217
Expenses$129,675
Net income−$112,458
Net assets$29,176
Notable sources of revenue
Percent of total revenue
Contributions
$17,217
100.0%
Program services
—
—
Investment income
—
—
Other (net)
$0
0.0%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$29,176
Compensation
Not in our extract for this year.
Fiscal year ending July2023
Revenue$161,277
Expenses$20,691
Net income$140,586
Net assets$141,634
Notable sources of revenue
Percent of total revenue
Contributions
$161,277
100.0%
Program services
—
—
Investment income
—
—
Other (net)
$0
0.0%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$141,634
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?